Conference Proceedings

In this NNI symposia at ESPGHAN 2024, three experts speak more about the future of HMOs, and how moving towards synbiotics can be a means to optimize health benefits. Prof. Lorella Gianni shares updates regarding many complementary functions of HMOs, and its role in supporting gut and immune development in early life, which may be used to address and potentially prevent health conditions such as allergies and infections. Prof. Jean-Charles Picaud discusses the results of a clinical study with a synbiotic blend of six HMOs and strain specific probiotics showing positive influence on the infant

Enteral nutrition has evolved immensely in recent years, such as in feeding approaches and products. With this, more patients with pediatric chronic conditions have improved prognosis and life expectancy. Improving nutritional status has not only allowed for survival, but has also enhanced the patient’s health and quality of life. This symposium featured Prof. Frederic Gottrand, Prof. Valerie Marchand, and Dr. Graeme O’Connor, discusses details of weaning patients from enteral nutrition, new evidence on whether real food-based nutrition may improve tolerance to enteral nutrition in children

Food allergies are a growing health epidemic, with population-based surveys in the USA estimating that up to 8% of children and 11% of adults are now living with a food allergy. During the 1990s and early 2000s, international guidelines recommended the avoidance of commonly problematic food during infancy due to the belief that early introduction of these foods may increase the risk of allergies. However, beginning with the publication of the LEAP trial in 2015,3 a paradigm shift in the understanding of food allergy prevention has occurred. Clinical guidelines now generally recommend the